Navigation Links
Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board
Date:2/17/2010

CUPERTINO, Calif., Feb. 17 /PRNewswire / -- SI-BONE, Inc. (Cupertino, California), a medical device company that is pioneering the use of a minimally invasive surgical device to treat sacroiliac (SI) joint dysfunction today announced that several key luminary spine surgeons have joined the Company's Medical Advisory Board.  Drs. Frank M. Phillips, Paul A. Anderson and Federico P. Girardi join Drs. Steven R. Garfin (chair), Mark A. Reiley and A. Nick Shamie on the SI-BONE Medical Advisory Board.

Drs. Phillips, Anderson and Girardi are renowned spine surgeons with experience in low back pathologies.  They will work with the Company to provide SI joint-specific advice on education of surgeons and physiatrists, clinical trial and protocol design input, data review and comment, referrals to colleagues, presentations and publications in peer-reviewed meetings and medical journals, and editorial review of manuscripts and abstracts.  "I'm pleased to have my colleagues joining me on the SI-BONE advisory board," said Dr. Garfin.  He added, "I'm sure they will be invaluable in helping to get the word out on diagnosing SI joint problems and the "patient friendly" MIS treatment of patients with iFuse™ who have failed non-operative conservative medical therapy."

Dr. Phillips is an internationally recognized spine surgeon and an acknowledged expert in the field of motion preserving and minimally invasive spinal procedures. He has participated in the development of a number of minimally invasive spinal techniques and devices and has focused on research in biologics and biomechanics of spinal reconstruction.  He is a graduate from the University of Witwatersrand Medical School, Johannesburg, South Africa, completed his orthopedic residency at The University of Chicago and served a spine fellowship at Case Western Reserve University School of Medicine. He is currently Professor of Orthopaedic Surgery and Head of the Section of Minimally Invasive Spine Surgery at Rush University Medical Center. He publishes and lectures extensively and directs spinal educational courses for other surgeons. Dr. Phillips is Past President of the Society for Minimally Invasive Spine Surgery and is on various committees of the Cervical Spine Research Committee and the Society for Advanced Spine Surgery (SAS).  

Dr. Anderson is a leading academic and Professor of Orthopedic Surgery at the University of Wisconsin in Madison.  He is a graduate of Wayne State University Medical School in Detroit, MI where he also served his residency in orthopedic surgery.  He served his fellowship in spine surgery at Case Western Reserve University in Cleveland, OH.  His clinical specialties are varied and numerous and he is the author and editor of numerous spine and orthopedic surgery textbooks and publications.  Dr. Anderson is certified by the American Board of Orthopedic Surgery and is a nationally recognized expert in spinal trauma and complex cervical spine disorders. His research specialties include spinal fixation implants, the development of an artificial cervical disc, and basic research in disc regeneration.

Dr. Girardi is an internationally renowned spine surgeon who specializes in the surgical treatment of different spinal disorders, including degenerative disease and stenosis, deformity, osteoporosis, fractures, and tumors of the cervical, thoracic and lumbar spine.  He has extensive experience in clinical research involving the areas of minimally invasive surgery, clinical outcomes of different surgical procedures, and imaging modalities of the spine. His interests include basic science aspects of bone, disc and nerve tissue regeneration as well as the investigation of alternatives to spinal fusion for the treatment of degenerative disc disease.  Dr. Girardi is Associate Attending Orthopaedic Surgeon at the Hospital for Special Surgery and Associate Professor of Orthopedics at Weill Cornell Medical College.  He earned his medical degree at Universidad Nacional de Rosario in Argentina and served his residency at Buenos Aires University in orthopedic surgery and trauma in Buenos Aires, Argentina.  His fellowship was served in the Hospital for Special Surgery, Spine & Scoliosis Surgery in New York.  

Jeffrey Dunn, President and Chief Executive Officer of SI-BONE, commented, "We are honored that these world-renowned specialists have agreed to join SI-BONE's Medical Advisory Board. They all bring extensive clinical experience and a very patient-centric intense focus to our Medical Advisory Board. We expect to benefit from their insights and expertise as we continue to seek to position MIS SI Joint fusion among the frontline therapies for patients with unresolved chronic low back symptoms refractory to conservative medical therapy.  Our MAB members have already assisted with the development of our recently announced strategies to reach out to other spine surgeons and pain specialists, and we look forward to their further contributions in 2010 and beyond."

In response to increasing awareness of SI Joint dysfunction as a debilitating symptom generator, SI-BONE, Inc. developed an innovative, patented, intramedullary implant to treat the SI Joint.   The company is also planning a post-market multicenter study to determine its effect over time on SI Joint pathology and on symptoms associated with SI Joint dysfunction.

The iFuse Implant System is a commercially available device in the US intended for fracture fixation of large bones and large bone fragments of the pelvis for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.  The iFuse procedure uses a minimal incision for delivery and implantation of small, titanium implants.  The implants are coated with a porous plasma spray that acts as an interference surface, designed to help decrease implant motion.  These implants have substantial thickness and sophisticated metallurgy and are able to produce a much stronger construct than that of conventional pins or screws used to surgically fix boney structures.  This implant technology from SI-BONE has been previously used successfully in approximately 1,000 cases of dysfunctional foot joints.

About SI-BONE, Inc.

SI-BONE, Inc. (Cupertino, California) is a leading spinal medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to sacroiliac (SI) joint pathology.  The company has developed, and is manufacturing and marketing, less invasive approaches using implants for the treatment of SI Joint pathology.  SI-BONE has an experienced management team with extensive experience in orthopedic and spine medical devices.

SOURCE SI-BONE, Inc.


'/>"/>
SOURCE SI-BONE, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Combined Pharma Event Visitor Numbers 5% Ahead of 2008 Frankfurt Record
2. Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
3. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
4. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
5. Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
6. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
7. Help is Here Express Arrives in Anderson, Seneca
8. HS-7 Document Regarding Research @ M. D. Anderson Orlando
9. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
10. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
11. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... 2017 The new research portal ... comprehensive collection of company reports on UnitedHealth Group ... of their activities in the healthcare industry. ...      ... is going through a fundamental transformation globally-a shift from ...
(Date:3/30/2017)... Julie & Lefkowitz LLP, a class action law firm dedicated ... fiduciary duty claim involving the board of directors of Synergy ... If you are a shareholder of Synergy Pharmaceuticals and are ... charge, please visit us at: ... http://pjlfirm.com/synergy-pharmaceuticals-inc/ ...
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets has ... report to their offering. ... The global gas chromatograph market to grow at ... The report, Global Gas Chromatograph Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 29, 2017 , ... In the United States alone, up to 36% of ... types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are ... more effective treatment options, the San Diego Gamma Knife Center offers a ...
(Date:3/29/2017)... , ... March 30, 2017 , ... Grass pollen is the main cause of hay ... the stuff. The season for grass pollen runs from May to July each year; with ... fever victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy ... "Wonder Spice", it has been used for thousands of years. , "The West has ... author of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Patients interested in receiving ... from Dr. Jamie Cameron, with or without a referral. The FASTBRACES system is ... Depending on each patient’s case, treatment with the FASTBRACES system could be completed ...
Breaking Medicine News(10 mins):